Sep 10, 2024 Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders We are pleased to announce three new UK DRI Emerging Leaders: Dr Maura Malpetti, Dr... Learn more Shaping the future of dementia research: Meet the UK DRI’s newest Emerging Leaders
Jan 01, 2024 Why partner with the UK DRI? The UK DRI is central to a rich and connected dementia research ecosystem, and we... Learn more Why partner with the UK DRI?
Jan 01, 2024 Why join the UK DRI? By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists... Learn more Why join the UK DRI?
News Jun 19, 2025 - Update Between the signals: UK DRI at King’s launches new public podcast ahead of Global MND Awareness Day The team from UK DRI at King’s have launched a new podcast ‘Between the signals’... Learn more Between the signals: UK DRI at King’s launches new public podcast ahead of Global MND Awareness Day Jun 18, 2025 - Comment UK Dementia Research Institute responds to NICE guidance on the use of donanemab and lecanemab for Alzheimer’s disease The National Institute for Health and Care Excellence (NICE) have today published their final draft... Learn more UK Dementia Research Institute responds to NICE guidance on the use of donanemab and lecanemab for Alzheimer’s disease Jun 17, 2025 - Update Welcoming a new Group Leader, Paresh Malhotra, to the UK DRI Centre for Care Research & Technology We are pleased to announce the appointment of a new Group Leader, Prof Paresh Malhotra... Learn more Welcoming a new Group Leader, Paresh Malhotra, to the UK DRI Centre for Care Research & Technology
Jun 19, 2025 - Update Between the signals: UK DRI at King’s launches new public podcast ahead of Global MND Awareness Day The team from UK DRI at King’s have launched a new podcast ‘Between the signals’... Learn more Between the signals: UK DRI at King’s launches new public podcast ahead of Global MND Awareness Day
Jun 18, 2025 - Comment UK Dementia Research Institute responds to NICE guidance on the use of donanemab and lecanemab for Alzheimer’s disease The National Institute for Health and Care Excellence (NICE) have today published their final draft... Learn more UK Dementia Research Institute responds to NICE guidance on the use of donanemab and lecanemab for Alzheimer’s disease
Jun 17, 2025 - Update Welcoming a new Group Leader, Paresh Malhotra, to the UK DRI Centre for Care Research & Technology We are pleased to announce the appointment of a new Group Leader, Prof Paresh Malhotra... Learn more Welcoming a new Group Leader, Paresh Malhotra, to the UK DRI Centre for Care Research & Technology
